PMID- 30761929 OWN - NLM STAT- MEDLINE DCOM- 20200610 LR - 20200610 IS - 1747-6356 (Electronic) IS - 1747-6348 (Linking) VI - 13 IP - 4 DP - 2019 Apr TI - Emphysema: looking beyond alpha-1 antitrypsin deficiency. PG - 381-397 LID - 10.1080/17476348.2019.1580575 [doi] AB - Distinct pathologies can cause chronic obstructive pulmonary disease (COPD). Emphysema is a COPD-phenotype characterized by destruction of lung parenchyma. Alpha-1 antitrypsin deficiency (AATD) is a genetic cause of emphysema, whereas smoking is the most important risk factor of non-AATD emphysema. A general underappreciation of non-AATD emphysema has hampered progress in the field, and clinical guidelines have prohibited the use of emphysema as a diagnosis. Non-AATD emphysema, however, is far from irrelevant as it associates with dyspnea, reduced exercise capacity and relevant outcome measures. Areas covered: Mechanisms underlying enhanced tissue loss in emphysema are protease/antiprotease imbalance, increased oxidative stress, several fundamental cell biological processes such as programmed cell death and autophagy, and impaired repair mechanisms. Therapeutic options for emphysema vary from smoking cessation to lung volume reduction. Current pharmacological treatments have less favorable effects in emphysematous than in non-emphysematous COPD patients. Expert opinion: We advocate the acknowledgment of non-AATD emphysema as a clinical diagnosis and propose to end the era of bringing all pathologies that may lead to chronic airflow limitation together under the umbrella-term of COPD. Decelerating proteolysis and restoring damage should be main targets in emphysema. Vitamin A/K, hyaluronan, copper and roflumilast are promising candidates. FAU - Janssen, Rob AU - Janssen R AD - a Department of Pulmonary Medicine , Canisius-Wilhelmina Hospital , Nijmegen , The Netherlands. FAU - Piscaer, Ianthe AU - Piscaer I AD - b Department of Respiratory Medicine , Maastricht University Medical Center , Maastricht , The Netherlands. AD - c NUTRIM School of Nutrition and Translational Research in Metabolism , Maastricht University Medical Center , Maastricht , The Netherlands. FAU - Franssen, Frits M E AU - Franssen FME AD - b Department of Respiratory Medicine , Maastricht University Medical Center , Maastricht , The Netherlands. AD - c NUTRIM School of Nutrition and Translational Research in Metabolism , Maastricht University Medical Center , Maastricht , The Netherlands. AD - d CIRO , Center of Expertise for Chronic Organ Failure , Horn , The Netherlands. FAU - Wouters, Emiel F M AU - Wouters EFM AD - b Department of Respiratory Medicine , Maastricht University Medical Center , Maastricht , The Netherlands. AD - c NUTRIM School of Nutrition and Translational Research in Metabolism , Maastricht University Medical Center , Maastricht , The Netherlands. AD - d CIRO , Center of Expertise for Chronic Organ Failure , Horn , The Netherlands. LA - eng PT - Journal Article PT - Review DEP - 20190222 PL - England TA - Expert Rev Respir Med JT - Expert review of respiratory medicine JID - 101278196 SB - IM MH - Animals MH - Female MH - Humans MH - Male MH - Pneumonectomy MH - Pulmonary Disease, Chronic Obstructive/*etiology MH - Pulmonary Emphysema/complications/diagnosis/pathology/*therapy MH - Smoking/adverse effects MH - Smoking Cessation MH - alpha 1-Antitrypsin Deficiency/complications OTO - NOTNLM OT - COPD OT - Emphysema OT - antiproteases OT - centrilobular emphysema OT - elastin degradation OT - elastin repair OT - non-alpha1 antitrypsin emphysema OT - panlobular emphysema OT - paraseptal emphysema OT - proteases EDAT- 2019/02/15 06:00 MHDA- 2020/06/11 06:00 CRDT- 2019/02/15 06:00 PHST- 2019/02/15 06:00 [pubmed] PHST- 2020/06/11 06:00 [medline] PHST- 2019/02/15 06:00 [entrez] AID - 10.1080/17476348.2019.1580575 [doi] PST - ppublish SO - Expert Rev Respir Med. 2019 Apr;13(4):381-397. doi: 10.1080/17476348.2019.1580575. Epub 2019 Feb 22.